Evidence map›Paper›PMID 10908325›Full record

ArticleNucleic acids research2000

The identification of an endonuclease that cleaves within an HuR binding site in mRNA.

Z Zhao, F C Chang, H M Furneaux

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. RNA-binding proteins implicated in the hypoxic response.Journal of cellular and molecular medicine · 2009
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Mechanisms of endonuclease-mediated mRNA decay.Wiley interdisciplinary reviews. RNA
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Z ZhaoProgram in Molecular Pharmacology and Therapeutics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.
F C Chang
H M Furneaux
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
REGULATION OF VEGF MRNA STABILITY BY HYPOXIAR01HL058510 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI FURNEAUX, HENRY M · 1999 to 2002
$920k
NCI NIH HHS P30 CA008748NCI NIH HHS P30-CA08748NHLBI NIH HHS R01-HL 58510
6 · The paper itself

Abstract

Messenger RNAs (mRNAs) that contain U-rich elements are targeted for rapid decay. Selective inhibition of this decay results in a rapid increase in steady state level. Thus, this is an important regulatory step in gene expression. Previously, we have found that these mRNAs are selectively stabilized by a specific mRNA binding protein called HuR. The mechanism of action of HuR is not well understood. It has been postulated that HuR stabilizes mRNA by the displacement or inhibition of factors that specifically cleave or deadenyl-ate these mRNAs. In this paper, we report the identification and characterization of a novel endo-nuclease that cleaves within an HuR binding site in p27kip1 mRNA. The specificity of this endonuclease and its inhibition by HuR argue for it playing a role in the postranscriptional regulation of gene expression.

Indexed as

Antigens, SurfaceBase SequenceBinding SitesELAV-Like Protein 1ELAV ProteinsEndonucleasesHeLa CellsHumansRNA-Binding ProteinsRNA, MessengerSubstrate SpecificityAntigens, SurfaceELAVL1 protein, humanELAV-Like Protein 1ELAV ProteinsEndonucleasesRNA-Binding ProteinsRNA, Messenger

Identifiers

PMID10908325
PMCPMC102663
OpenAlexW2125915128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.